Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study
Clinical Infectious Diseases · 08.06.2023 · 76 (11) · 1930-1941
DOI: 10.1093/cid/ciad045 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 27.01.2023. Verfasst von Michael Gottlieb und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, CDC HHS, National Center for Immunization and Respiratory Diseases, CDC.
Abstract (Originalsprache)
Background
Most research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants focuses on initial symptomatology with limited longer-term data. We characterized prevalences of prolonged symptoms 3 months post–SARS-CoV-2 infection across 3 variant time-periods (pre-Delta, Delta, and Omicron).
Methods
This multicenter prospective cohort study of adults with acute illness tested for SARS-CoV-2 compared fatigue severity, fatigue symptoms, organ system–based symptoms, and ≥3 symptoms across variants among participants with a positive (“COVID-positive”) or negative SARS-CoV-2 test (“COVID-negative”) at 3 months after SARS-CoV-2 testing. Variant periods were defined by dates with ≥50% dominant strain. We performed multivariable logistic regression modeling to estimate independent effects of variants adjusting for sociodemographics, baseline health, and vaccine status.
Results
The study included 2402 COVID-positive and 821 COVID-negative participants. Among COVID-positives, 463 (19.3%) were pre-Delta, 1198 (49.9%) Delta, and 741 (30.8%) Omicron. The pre-Delta COVID-positive cohort exhibited more prolonged severe fatigue (16.7% vs 11.5% vs 12.3%; P = .017) and presence of ≥3 prolonged symptoms (28.4% vs 21.7% vs 16.0%; P < .001) compared with the Delta and Omicron cohorts. No differences were seen in the COVID-negatives across time-periods. In multivariable models adjusted for vaccination, severe fatigue and odds of having ≥3 symptoms were no longer significant across variants.
Conclusions
Prolonged symptoms following SARS-CoV-2 infection were more common among participants infected during pre-Delta than with Delta and Omicron; however, these differences were no longer significant after adjusting for vaccination status, suggesting a beneficial effect of vaccination on risk of long-term symptoms. Clinical Trials Registration. NCT04610515.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, USA.
- Department of Emergency Medicine, University of California, San Francisco, California, USA.
- Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.
- Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
- Department of Emergency Medicine, University of California - San Francisco School of Medicine, San Francisco, California, USA.
ORCID-Profile: Michael Gottlieb, Ralph C Wang, Robert M Rodriguez, Joann G Elmore, Ian D Plumb, Lauren E Wisk, Arjun Venkatesh, Robert A Weinstein
Förderung
- NCATS NIH HHS
- CDC HHS
- National Center for Immunization and Respiratory Diseases, CDC
Zitieren
APA
Gottlieb, M., Wang, R. C., Yu, H., Spatz, E. S., Montoy, J. C. C., Rodriguez, R. M., Chang, A. M., Elmore, J. G., Hannikainen, P. A., Hill, M., Huebinger, R. M., Idris, A. H., Lin, Z., Koo, K., McDonald, S., O'Laughlin, K. N., Plumb, I. D., Santangelo, M., Saydah, S., …, & Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group (2023). Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study. Clinical Infectious Diseases, 76(11), 1930-1941. https://doi.org/10.1093/cid/ciad045
Vancouver
Gottlieb M, Wang RC, Yu H, Spatz ES, Montoy JCC, Rodriguez RM, et al. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study. Clinical Infectious Diseases. 2023;76(11):1930-1941. doi:10.1093/cid/ciad045
BibTeX
@article{Gottlieb2023,
author = {Gottlieb, Michael and Wang, Ralph C and Yu, Huihui and Spatz, Erica S and Montoy, Juan Carlos C and Rodriguez, Robert M and Chang, Anna Marie and Elmore, Joann G and Hannikainen, Paavali A and Hill, Mandy and Huebinger, Ryan M and Idris, Ahamed H and Lin, Zhenqiu and Koo, Katherine and McDonald, Samuel and O'Laughlin, Kelli N and Plumb, Ian D and Santangelo, Michelle and Saydah, Sharon and Willis, Michael and Wisk, Lauren E and Venkatesh, Arjun and Stephens, Kari A and Weinstein, Robert A and Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group, Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group},
title = {Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {76},
number = {11},
pages = {1930--1941},
doi = {10.1093/cid/ciad045}
}
EUVIMED